(S)-3-(3-(4-Methylpiperazin-1-yl)phenyl)-4-oxo-4-((R)-3-(2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethyl)pyrrolidin-1-yl)butanoic acid

ID: ALA4756649

PubChem CID: 162655364

Max Phase: Preclinical

Molecular Formula: C29H39N5O3

Molecular Weight: 505.66

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CN1CCN(c2cccc([C@H](CC(=O)O)C(=O)N3CC[C@@H](CCc4ccc5c(n4)NCCC5)C3)c2)CC1

Standard InChI:  InChI=1S/C29H39N5O3/c1-32-14-16-33(17-15-32)25-6-2-4-23(18-25)26(19-27(35)36)29(37)34-13-11-21(20-34)7-9-24-10-8-22-5-3-12-30-28(22)31-24/h2,4,6,8,10,18,21,26H,3,5,7,9,11-17,19-20H2,1H3,(H,30,31)(H,35,36)/t21-,26+/m1/s1

Standard InChI Key:  QEDWYURCTRDSED-RLWLMLJZSA-N

Molfile:  

 
     RDKit          2D

 37 41  0  0  0  0  0  0  0  0999 V2000
    1.6055   -7.5611    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6055   -8.3783    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3108   -8.7827    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.3108   -7.1484    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0161   -7.5611    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0126   -8.3783    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7146   -8.7876    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.4247   -8.3843    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4281   -7.5671    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7216   -7.1532    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1301   -8.7968    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8401   -8.3922    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5455   -8.8048    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6229   -9.6141    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4213   -9.7885    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8339   -9.0830    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.2904   -8.4728    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6471   -9.0021    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1237   -9.6659    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9836   -8.2574    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.7872  -10.4106    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9369   -9.5850    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9744  -10.4884    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6378  -11.2322    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1146  -11.8970    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9318  -11.8130    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2646  -11.0690    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4136  -10.2488    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2267  -10.1679    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.0770  -10.9935    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.4127  -12.4728    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.0771  -13.2178    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.5543  -13.8758    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.3669  -13.7934    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.7001  -13.0470    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.2206  -12.3830    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8458  -14.4556    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  4  1  0
  2  3  1  0
  3  6  1  0
  5  4  1  0
  5  6  2  0
  5 10  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
  8 11  1  0
 11 12  1  0
 13 12  1  1
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 13  1  0
 16 18  1  0
 18 19  1  0
 18 20  2  0
 19 21  1  1
 19 22  1  0
 21 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 21  1  0
 22 28  1  0
 28 29  1  0
 28 30  2  0
 26 31  1  0
 31 32  1  0
 31 36  1  0
 32 33  1  0
 33 34  1  0
 34 35  1  0
 35 36  1  0
 34 37  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4756649

    ---

Associated Targets(Human)

ITGB3 Tclin Integrin alpha-V/beta-3 (2708 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ITGAV Tchem Integrin alpha-V/beta-5 (589 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 505.66Molecular Weight (Monoisotopic): 505.3053AlogP: 3.23#Rotatable Bonds: 8
Polar Surface Area: 89.01Molecular Species: ACIDHBA: 6HBD: 2
#RO5 Violations: 1HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 4.24CX Basic pKa: 8.06CX LogP: 0.11CX LogD: 0.08
Aromatic Rings: 2Heavy Atoms: 37QED Weighted: 0.57Np Likeness Score: -0.68

References

1. Lippa RA,Barrett J,Pal S,Rowedder JE,Murphy JA,Barrett TN.  (2020)  Discovery of the first potent and selective αβ integrin inhibitor based on an amide-containing core.,  208  [PMID:32865176] [10.1016/j.ejmech.2020.112719]

Source